Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma
- PMID: 33567541
- PMCID: PMC7915502
- DOI: 10.3390/cancers13040673
Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma
Abstract
Most reports about copy number alterations (CNA) in retinoblastoma relate to patients with intraocular disease and features of children with extraocular relapse remain unknown, so we aimed to describe the CNA in this population. We evaluated 23 patients and 27 specimens from 4 centers. Seventeen cases had extraocular relapse after initial enucleation and six cases after an initial preservation attempt. We performed an analysis of CNA and BCOR gene alteration by SNP array (Single Nucleotide Polymorfism array), whole-exome sequencing, IMPACT panel and CGH array (Array-based comparative genomic hybridization). All cases presented CNA at a higher prevalence than those reported in previously published studies for intraocular cases. CNA previously reported for intraocular retinoblastoma were found at a high frequency in our cohort: gains in 1q (69.5%), 2p (60.9%) and 6p (86.9%), and 16q loss (78.2%). Other, previously less-recognized, CNA were found including loss of 11q (34.8%), gain of 17q (56.5%), loss of 19q (30.4%) and BCOR alterations were present in 72.7% of our cases. A high number of CNA including 11q deletions, 17q gains, 19q loss, and BCOR alterations, are more common in extraocular retinoblastoma. Identification of these features may be correlated with a more aggressive tumor warranting consideration for patient management.
Keywords: BCOR mutations; copy number alteration; extraocular retinoblastoma; genomic; metastasis.
Conflict of interest statement
The authors declare no conflict of interest. The sponsors or funding organizations had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
References
-
- Munier F.L., Beck-Popovic M., Chantada G.L., Cobrinik D., Kivelä T.T., Lohmann D., Maeder P., Moll A.C., Carcaboso A.M., Moulin A., et al. Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. “Alive, with good vision and no comorbidity”. Prog. Retin. Eye Res. 2019;73:100764. doi: 10.1016/j.preteyeres.2019.05.005. - DOI - PubMed
-
- Lu J.E., Francis J.H., Dunkel I.J., Shields C.L., Yu M.D., Berry J.L., Kogachi K., Skalet A.H., Miller A.K., Santapuram P.R., et al. Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007–2017. Br. J. Ophthalmol. 2018;103:1272–1277. doi: 10.1136/bjophthalmol-2018-312915. - DOI - PMC - PubMed
-
- Chévez-Barrios P., Eagle R.C.E., Jr., Krailo M., Piao J., Albert D.M., Gao Y., Vemuganti G., Ali M.J., Khetan V., Honavar S.G., et al. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children’s Oncology Group Study. J. Clin. Oncol. 2019;37:2883–2891. doi: 10.1200/JCO.18.01808. - DOI - PMC - PubMed
-
- Aerts I., Sastre-Garau X., Savignoni A., Rouic L.L.-L., Thebaud-Leculée E., Frappaz D., Coze C., Thomas C., Gauthier-Villars M., Lévy-Gabriel C., et al. Results of a Multicenter Prospective Study on the Postoperative Treatment of Unilateral Retinoblastoma After Primary Enucleation. J. Clin. Oncol. 2013;31:1458–1463. doi: 10.1200/JCO.2012.42.3962. - DOI - PubMed
Grants and funding
- Fund for Ophthalmic knowledge 2019-2020/Fund for Ophthalmic Knowledge
- Aid for investigation and research in Paediatric Oncology/Fundación Natalie Dafne Flexer de Ayuda al Niño con Cancer
- Fund for metastatic retinoblastoma (2019-2021)/Fondation Nelia et Amadeo Barletta
- Fund for children with cancer/Fundación Leo Messi
- Subsidio de la Fundación Garrahan para el estudio del retinoblastoma de alto riesgo (2018-2020)/Fundación Garrahan
LinkOut - more resources
Full Text Sources
Other Literature Sources
